Cross Presentation and tumour immunology
Cross Presentation and tumour immunology
批准号:
nhmrc : 1029589
负责人:
Prof Anna Nowak
金额:
$29.68万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2012
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2012-01-01 至 2015-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cancers have thousands of mutations, so they should look a bit like a viral infection. If so, why doesn’t the immune system just destroy them outright, like they would a virus? We think the mutated proteins cause a ‘brake’ to be put on the anti-cancer immune response, and also that cancers subvert the anti-cancer attack by remaining hidden in the target zone. Unblocking these “brakes” might lead to new treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving treatment outcomes for malignant mesothelioma patients using biomarkers.
-
批准号:nhmrc : 1063067
-
项目类别:Project Grants
-
资助金额:$53.03万
-
财政年份:2014
-
负责人:Prof Anna Nowak
-
依托单位:
Can biomarkers improve outcomes for the asbestos-induced cancer malignant mesothelioma?
-
批准号:nhmrc : GNT1063067
-
项目类别:Project Grants
-
资助金额:$51.28万
-
财政年份:2014
-
负责人:Prof Anna Nowak
-
依托单位:
National Centre for Asbestos Related Diseases
-
批准号:nhmrc : 1001020
-
项目类别:Centres of Research Excellence
-
资助金额:$341.4万
-
财政年份:2010
-
负责人:Prof Anna Nowak
-
依托单位:
海外基金